Outcomes after alemtuzemab-containing reduced-intensity allogeneic transplantation regimen for relapsed and refractory non-Hodgkin lymphoma

E Morris, K Thomson, Charles Craddock, Premini Mahendra, Donald Milligan, G Cook, GM Smith, A Parker, S Schey, R Chopra, C Hatton, J Tighe, A Hunter, K Peggs, D Linch, A Goldstone, S Mackinnon

Research output: Contribution to journalArticle

259 Citations (Scopus)
Original languageEnglish
Pages (from-to)3865-3871
Number of pages7
Publication statusPublished - 1 Jan 2004

Cite this